
## **Trustees' Annual Report for the period** 

||Period start date|Period start date|||Period end date||
|---|---|---|---|---|---|---|
|**From**|**01**|**April**|**2024**|**To**|**31**<br>**March**|**2025**|



## Section A                        Reference and administration details 

**Charity name** British Dupuytren's Society 

**Other names charity is known by** BDS 

> **Registered charity number (if any)** 1176333 

**Charity's principal address** 22, Wainfleet Close, Winstanley, Wigan 

**Postcode WN3 6TG** 

## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (if any)**|
|---|---|---|---|---|
||A Schurer|Chair|||
||H. Giele||||
||D. Furniss||||
||R. Shaffer||||
||G. Flanaghan||||
||D.Ralph||||
||G. Manley||||
||A. McNish|Treasurer|||
||||||



## **Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

|**Name**|**Dates acted if not for whole year**|
|---|---|
|none||
|||
|||



## **Names and addresses of advisers** 

|**Type of adviser**<br>**Name**<br>**Address**|**Type of adviser**<br>**Name**<br>**Address**|**Type of adviser**<br>**Name**<br>**Address**|
|---|---|---|
|**Financial**<br>|Tim Read||
||||



## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

CIO Type of governing document ) 

March **2012** 

**TAR** 

1 



Legal Company 

How the charity is constituted 

(eg. trust, association, company) 

## Trustee selection methods 

(eg. appointed by, elected by) 

References are taken and many are known Senior Doctors and Consultants working in the NHS treating patients who have Dupuytren’s Disease, Ledderhose or Peyronies Disease. 

## **Section C                    Objectives and activities** 

To support patients, help them cope their diagnosis and find the treatment appropriate to them. To support researchers and doctors running trials via Patients and Public Involvement.  Attending meetings **Summary of the objects of the** and advising patients of ongoing trials so they can join in wished.  To **charity set out in its** disseminate research and trial findings to the wider community of patients **governing document** and doctors. 

Maintain and updating our website and blogs for the wider public so they have relevant information. Running Facebook Groups and pages, twitter and Mastadon again for the wider public so they can find information about Dupuytrens Contracture and Ledderhose issues.  Providing a response to email enquiries from patients, doctors and researchers. Providing worldwide information on Trials and tests so that patients suffering from these issues (“diathesis patients”).  We connect with a large group of trainee hand surgeons to educate and help them. 

We strive to raise worldwide (and especially in the UK) awareness of Dupuytrens Contracture, Ledderhose and similar issues like Peyronies Disease. 

**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

March **2012** 

**TAR** 

2 



Section D                      Achievements and performance 

March **2012** 

**TAR** 

3 



## Section D                      Achievements and performance 

**Summary of the main achievements of the charity during the year** 

Our Chair attended the 2025 Worldwide Conference in Belgium and made many new contacts.  Our Chair is also now part of the Federation of European Societies for Surgery of the Hand (FESSH) Sub Group, investigating surgery techniques for Dupuytren’s Contracture and similar health issues. 

Our charity continues to search for new or better techniques to improve treatments for Dupuytren’s Disease, Ledderhose and Peyronies health issues. 

We have funded research for the Anglia Ruskin University for the sum pf £20,000 for Peyronie's Disease.  These funds were from a donation by E Ashby in November 2023.  We have issued the first payment in December 2024. 

We have instituted a new page on our website that gives important news on the issues related to the those which are important to the objectives of our charity listed by year. 

Our long standing Trustee Annemarie Mcnish who has managed our finances for many years stood down the summer of 2025 and was thanked for her long service to the charity. 

March **2012** 

**TAR** 

4 



## **Section E                    Financial review** 

The Trustees are very careful to review and minimise our costs in line **Brief statement of the** with our income. 

**charity’s policy on reserves** 

**Details of any funds materially** None **in deficit** 

**Further financial review details (Optional information)** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

## **Signed on behalf of the charity’s trustees** 

## **Signature(s)** 


**Full name(s)** Anna Schurer 

**Position (eg Secretary, Chair,** Chair **etc)** 

**Date** 30/07/25 

March **2012** 

**TAR** 

5 




**British Dupuytrens Society 1176333 Receipts and payments accounts For the period Period start date** Period end date **To from** 01-Apr-24 01-Apr-25 

## **CC16a** 

|**Section A Receipts and payments**|**Section A Receipts and payments**||||||
|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**844**<br>**1,815**<br>**25**<br>**614**<br>**273**<br>**-**<br>**-**<br>**-**<br>**-**<br>**3,571**<br>**-**<br>**-**<br>**-**<br>**3,571**<br>**60**<br>**100**<br>**242**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **402**<br>**-**<br>**-**<br> **-**<br>**402**<br>**3,169**<br>**-**<br>**17,160**<br>**20,329**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**10,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**10,000**<br>**-**<br>**-**<br>**-**<br>**10,000**<br>**-               10,000**<br>**-**<br>**22,300**<br>**12,300**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**844**<br>**1,815**<br>**25**<br>**614**<br>**273**<br>**-**<br>**-**<br>**-**# <br>**-**<br>**3,571**<br>**-**<br>**-**<br>**-**<br>**3,571**<br>**60**<br>**100**<br>**242**<br>**10,000**<br>**-**<br>**-**<br>**-**#<br>**-**<br>**10,402**<br>**-**<br>**-**<br>**-**<br>**10,402**<br>**-                 6,831**||**Last year**<br>**to the nearest £**|
|Much Loved|**844**|||||**-**|
|Neil Crossland|**1,815**|||||**-**|
|CAF|**25**|||||**-**|
|Bank Interest|**614**|||||**109**|
|Paypal|**273**|||||**-**|
|Sundry|**-**|||||**50**|
|Trevor Ryder||||||**240**|
|Amazon||||||**78**|
||||||||
|Enthuse||||||**688**|
|HMRC Gift Aid|**-**|||||**175**|
|BSH Day|**-**|||||**-**|
|C AshbyResricted Income|**-**|||||**22,300**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**3,571**|||||**23,640**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
|||||||**23,640**|
||||||||
|Bank Charges|**60**|||||**60**|
|Internet help|**100**|||||**50**|
|Site Ground|**242**|||||**-**|
|Rearch Payment Anlia Ruskin Uni|**-**|||||**-**|
|Postage|**-**|||||**69**|
|Banner|**-**|||||**40**|
|Web Domain(2yearr cost)|**-**|||||**36**|
|BSH Day|**-**|||||**172**|
||**-**|||||**-**|
|**_Sub total_ **|**402**|||||**427**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**427**|
||||||||
||**3,169**|**-               10,000**||**-                 6,831**||**23,213**|
||**-**|**-**||||**-**|
||**17,160**|**22,300**||**39,460**||**16,247**|
||**20,329**|**12,300**||**32,629**||**39,460**|



CCXX R1 accounts (SS) 

13/12/2025 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B4 Assets retained for the**<br>**h**<br>**i**<br>**’**<br>**B5 Liabilities**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**|Signature<br>**Details**<br>**Details**<br>Current Account HSBC<br>Deposit Account<br>paypal<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**3,292**<br>**-**<br>**13,923**<br>**12,300**<br>**3,114**<br>**-**<br>**20,329**<br>**12,300**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>Print Name<br>Anna Schurer|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
||||Date of<br>approval|
|||Anna Schurer|30//07/2025|
|||||



CCXX R2 accounts (SS) 

13/12/2025 

2 

